Opioid withdrawal assessment

The manuals converge on the need to assess opioid withdrawal in a structured way, using standardised ratings or comparable measures to track symptoms over time. Across the extracts, withdrawal assessment is tied to observing change before and after treatment or dosing, and to using those changes to understand treatment effects and patient status. They also agree that withdrawal data need careful interpretation. One manual emphasises observing specific withdrawal signs and distinguishing them from ibogaine effects, while another notes that concurrent study design factors may confound outcomes. The observational study focuses more narrowly on pre-treatment and immediate post-treatment symptom change, whereas the safety study highlights trends across multiple time points. The main differences are in emphasis and timing. The 2003 manual gives the most detailed clinical picture, naming both OOWS and SOWS and listing specific signs such as yawning, rhinorrhoea, piloerection, lacrimation, mydriasis, tremor, hot and cold flashes, restlessness, vomiting, cramps, and anxiety, with particular attention to complaints between 14 and 24 hours after treatment. The other sources are less granular, with one centring on the SOWS and immediate change, and the safety study focusing on total withdrawal scores and longitudinal trends.